Avanza Fonder Ab Veracyte, Inc. Call Options Transaction History
Avanza Fonder Ab
- $3.37 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VCYT
# of Institutions
338Shares Held
76.3MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$272 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$258 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$219 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$139 Million1.46% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$102 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.37B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...